Anti-tumour effect of low molecular weight heparin in localised lung cancer: a phase III clinical trial

The anti-tumour and anti-metastatic properties of heparins have not been tested in patients with early stage cancer. Whether adjuvant low molecular weight heparin (LMWH) tinzaparin impacts the survival of patients with resected non-small cell lung cancer (NSCLC) was investigated.Patients with comple...

Full description

Saved in:

Bibliographic Details
Published in:	The European respiratory journal Vol. 52; no. 4
Main Authors:	Meyer, Guy, Besse, Benjamin, Doubre, Hélène, Charles-Nelson, Anaïs, Aquilanti, Sandro, Izadifar, Armine, Azarian, Reza, Monnet, Isabelle, Lamour, Corinne, Descourt, Renaud, Oliviero, Gérard, Taillade, Laurent, Chouaid, Christos, Giraud, Frederique, Falcoz, Pierre-Emmanuel, Revel, Marie-Pierre, Westeel, Virginie, Dixmier, Adrien, Tredaniel, Jean, Dehette, Stéphanie, Decroisette, Chantal, Prevost, Alain, Pichon, Eric, Fabre, Elizabeth, Soria, Jean-Charles, Friard, Sylvie, Stern, Jean-Baptiste, Jabot, Laurence, Dennewald, Georges, Pavy, Gérard, Petitpretz, Patrick, Tourani, Jean-Marc, Alifano, Marco, Chatellier, Gilles, Girard, Philippe
Format:	Journal Article
Language:	English
Published:	England 01.10.2018
Subjects:	Aged Antineoplastic Combined Chemotherapy Protocols - therapeutic use Carcinoma, Non-Small-Cell Lung - drug therapy Carcinoma, Non-Small-Cell Lung - surgery Chemotherapy, Adjuvant Female France - epidemiology Heparin, Low-Molecular-Weight - therapeutic use Humans Injections, Subcutaneous Lung Neoplasms - drug therapy Lung Neoplasms - surgery Male Middle Aged Neoplasm Staging Survival Analysis Tinzaparin - therapeutic use France
ISSN:	1399-3003, 1399-3003
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!